Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $149.90 USD
Change Today +1.85 / 1.25%
Volume 6.6M
AMGN On Other Exchanges
Hong Kong
Sao Paulo
As of 8:10 PM 10/8/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by AMGEN INC (AMGN) in the last 6 months

Announced 09/16/15
1.55B for Dezima Pharma B.V.

Amgen Inc. (NasdaqGS:AMGN) entered into a definitive acquisition agreement to acquire Dezima Pharma B.V. from Forbion Capital Partners, BioGeneration Ventures Fund II, fund managed by BioGeneration Ventures B.V., New Science Ventures, LLC and others for $1.6 billion on September 16, 2015. Under the terms, Amgen Inc. will pay $300 million in cash and $1.3 billion additional payments if certain development and sales milestones are achieved. After completion Dezima Pharma ...
Read More

AMGN's price was unchanged after the transaction was announced on 09/16/15.
Investor / Buyer
Amgen Inc.
Creditor / Lender
BioGeneration Ventures B.V.
BioGeneration Ventures Fund II
Forbion Capital Partners
New Science Ventures, LLC
Financial Advisor
Moelis & Company
Legal Advisor
NautaDutilh N.V.
Announced 09/9/15
15.00M for Amgen Inc., Biological Medicines Manufacturing Facility In Boulder, Colorado

MedImmune, LLC acquired biological medicines manufacturing facility in Boulder, Colorado from Amgen Inc. (NasdaqGS:AMGN) for $14.6 million on September 9, 2015.

AMGN's price was unchanged after the transaction was announced on 09/9/15.
Investor / Buyer
MedImmune, LLC
Creditor / Lender
Amgen Inc.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMGN:US $149.90 USD +1.85

AMGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $56.04 USD 0.00
Allergan plc $276.16 USD +7.17
Eli Lilly & Co $83.77 USD -0.22
Medtronic PLC $72.05 USD 0.00
Novo Nordisk A/S kr357.30 DKK -1.00
View Industry Companies

Industry Analysis


Industry Average

Valuation AMGN Industry Range
Price/Earnings 19.6x
Price/Sales 5.4x
Price/Book 4.1x
Price/Cash Flow 19.3x
TEV/Sales 2.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at